![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
V Fafeur, B O'Hara and P Bohlen
Medical Research Division, American Cyanamid, Pearl River, New York 10965.
An endothelial cell line (M40) resistant to growth inhibition by transforming growth factor-beta type 1 (TGF beta 1) was isolated by chemical mutagenesis and growth in the presence of TGF beta 1. Like normal endothelial cells, this mutant is characterized by high expression of type II TGF beta receptor and low expression of type I TGF beta receptor. However, the mutant cells display a type II TGF beta receptor of reduced molecular weight as a result of a general defect in N-glycosylation of proteins. The alteration does not impair TGF beta 1 binding to cell surface receptors or the ability of TGF beta 1 to induce fibronectin or plasminogen activator inhibitor-type I production. M40 cells were also resistant to growth inhibition by tumor necrosis factor alpha (TNF alpha) and interleukin-1 alpha (IL-1 alpha) but were inhibited by interferon-gamma (IFN gamma) and heparin. These results imply that TGF beta 1, TNF alpha, and IL-1 alpha act through signal transducing pathways that are separate from pathways for IFN gamma and heparin. Basic fibroblast growth factor was still mitogenic for M40, further suggesting that TGF beta 1, TNF alpha, and IL-1 alpha act by direct inhibition of cell growth rather than by interfering with growth stimulatory pathways.
This article has been cited by other articles:
|
|
 |
|
  R. A. Anders and E. B. Leof Chimeric Granulocyte/Macrophage Colony-stimulating Factor/Transforming Growth Factor-beta (TGF-beta ) Receptors Define a Model System for Investigating the Role of Homomeric and Heteromeric Receptors in TGF-beta Signaling J. Biol. Chem., September 6, 1996; 271(36): 21758 - 21766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-H. Feng, E. H. Filvaroff, and R. Derynck Transforming Growth Factor-beta (TGF-beta)-induced Down-regulation of Cyclin A Expression Requires a Functional TGF-beta Receptor Complex J. Biol. Chem., October 13, 1995; 270(41): 24237 - 24245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Brand and M. D. Schneider Inactive Type II and Type I Receptors for TGFbeta Are Dominant Inhibitors of TGFbeta-dependent Transcription J. Biol. Chem., April 7, 1995; 270(14): 8274 - 8284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. M. Nauseef, S. J. McCormick, and R. A. Clark Calreticulin Functions as a Molecular Chaperone in the Biosynthesis of Myeloperoxidase J. Biol. Chem., March 3, 1995; 270(9): 4741 - 4747. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Finlay, V. J. Thannickal, B. L. Fanburg, and K. E. Paulson Transforming Growth Factor-beta 1-induced Activation of the ERK Pathway/Activator Protein-1 in Human Lung Fibroblasts Requires the Autocrine Induction of Basic Fibroblast Growth Factor J. Biol. Chem., September 1, 2000; 275(36): 27650 - 27656. [Abstract] [Full Text] [PDF]
|
|
